Duaklir Pressair and Ravicti

• Generic Name: aclidinium / formoterol
• Dosage Forms: n.a.
• Other Brand Names: Duaklir Pressair

Duaklir Pressair contains a combination of aclidinium and formoterol and is supplied as a breath activated multi-dose dry powder inhaler.

Duaklir Pressair is a prescription medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

Duaklir Pressair is for use only in people with COPD and should not be used to treat asthma.

• Generic Name: glycerol phenylbutyrate
• Dosage Forms: oral liquid
• Other Brand Names: Ravicti

Ravicti (glycerol phenylbutyrate) binds with other substances in the liver and kidneys to help eliminate nitrogen from the body. Excess nitrogen can cause hyperammonemia, a build-up of ammonia in the blood. Ammonia is very toxic when it circulates in blood and tissues and can cause permanent brain damage, coma, or death.

Ravicti helps prevent a build-up of ammonia in the blood in people with urea cycle disorder. This medicine is used in adults, children and infants. Ravicti will not treat hyperammonemia.

Ravicti is usually given together with a low-protein diet and sometimes dietary supplements.